Shannon Thyme Klinger
CIK 1866132 · View on SEC EDGAR ↗
Insider
First SEC filing: June 22, 2021 · Latest: June 8, 2026
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net:
$-173,550
+ 83 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
83 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 4, 2026 | MRNA | S | 3,471 | $50.00 | $173,550 | 67,468 | — | — | 186.5% (price as of 2026-08-20) |
| Dec. 9, 2024 | MRNA | S | 529 | $44.68 | $23,636 | 20,446 Direct | -2.52% | Disposed | 220.6% (price as of 2026-08-20) |
| Dec. 3, 2024 | MRNA | S | 112 | $43.30 | $4,850 | 19,837 Direct | -0.56% | Disposed | 230.8% (price as of 2026-08-20) |
| Nov. 29, 2024 | MRNA | S | 1,418 | $42.79 | $60,676 | 19,717 Direct | -6.71% | Disposed | 234.7% (price as of 2026-08-20) |
| Sept. 9, 2024 | MRNA | S | 551 | $73.57 | $40,537 | 18,154 Direct | -2.95% | Disposed | 94.7% (price as of 2026-08-20) |
| Sept. 3, 2024 | MRNA | S | 114 | $76.99 | $8,777 | 17,566 Direct | -0.64% | Disposed | 86.0% (price as of 2026-08-20) |
| Aug. 29, 2024 | MRNA | S | 162 | $78.03 | $12,641 | 17,447 Direct | -0.92% | Disposed | 83.6% (price as of 2026-08-20) |
| Aug. 28, 2024 | MRNA | S | 1,319 | $79.39 | $104,715 | 17,280 Direct | -7.09% | Disposed | 80.4% (price as of 2026-08-20) |
| June 10, 2024 | MRNA | S | 5,178 | $148.09 | $766,810 | 15,947 Direct | -24.51% | Disposed | -3.3% (price as of 2026-08-20) |
| June 3, 2024 | MRNA | S | 122 | $140.72 | $17,168 | 10,878 Direct | -1.11% | Disposed | 1.8% (price as of 2026-08-20) |
| May 29, 2024 | MRNA | S | 183 | $144.50 | $26,444 | 10,768 Direct | -1.67% | Disposed | -0.9% (price as of 2026-08-20) |
| May 28, 2024 | MRNA | S | 1,296 | $162.47 | $210,561 | 10,623 Direct | -10.87% | Disposed | -11.8% (price as of 2026-08-20) |
| March 8, 2024 | MRNA | S | 544 | $99.05 | $53,883 | 9,267 Direct | -5.54% | Disposed | 44.6% (price as of 2026-08-20) |
| March 4, 2024 | MRNA | S | 117 | $94.34 | $11,038 | 8,673 Direct | -1.33% | Disposed | 51.8% (price as of 2026-08-20) |
| Feb. 29, 2024 | MRNA | S | 670 | $94.57 | $63,362 | 8,557 Direct | -7.26% | Disposed | 51.5% (price as of 2026-08-20) |
| Dec. 8, 2023 | MRNA | S | 563 | $79.09 | $44,528 | 7,912 Direct | -6.64% | Disposed | 81.1% (price as of 2026-08-20) |
| Dec. 4, 2023 | MRNA | S | 111 | $79.31 | $8,803 | 7,336 Direct | -1.49% | Disposed | 80.6% (price as of 2026-08-20) |
Showing latest 100 of 134 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 28, 2025 | MRNA | Restricted Stock Units | Common Stock (329) | — | — | 329 | Disposed |
| Aug. 27, 2025 | MRNA | Restricted Stock Units | Common Stock (774) | — | — | 774 | Disposed |
| June 6, 2025 | MRNA | Restricted Stock Units | Common Stock (1,139) | — | — | 1,139 | Disposed |
| May 30, 2025 | MRNA | Restricted Stock Units | Common Stock (233) | — | — | 233 | Disposed |
| May 28, 2025 | MRNA | Restricted Stock Units | Common Stock (328) | — | — | 328 | Disposed |
| May 27, 2025 | MRNA | Restricted Stock Units | Common Stock (773) | — | — | 773 | Disposed |
| March 7, 2025 | MRNA | Restricted Stock Units | Common Stock (1,139) | — | — | 1,139 | Disposed |
| March 1, 2025 | MRNA | Restricted Stock Units | Common Stock (34,655) | — | — | 34,655 | Acquired |
| March 1, 2025 | MRNA | Stock Option (Right to Buy) | Common Stock (55,543) | $30.96 | March 1, 2035 | 55,543 | Acquired |
| Feb. 28, 2025 | MRNA | Restricted Stock Units | Common Stock (329) | — | — | 329 | Disposed |
| Feb. 28, 2025 | MRNA | Restricted Stock Units | Common Stock (233) | — | — | 233 | Disposed |
| Feb. 27, 2025 | MRNA | Restricted Stock Units | Common Stock (2,653) | — | — | 2,653 | Disposed |
| Feb. 27, 2025 | MRNA | Restricted Stock Units | Common Stock (3,094) | — | — | 3,094 | Disposed |
| Dec. 6, 2024 | MRNA | Restricted Stock Units | Common Stock (1,138) | — | — | 1,138 | Disposed |
| Dec. 5, 2024 | MRNA | Restricted Stock Units | Common Stock (188,761) | $0.00 | — | 188,761 | Acquired |
| Dec. 2, 2024 | MRNA | Restricted Stock Units | Common Stock (232) | — | — | 232 | Disposed |
| Nov. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (2,652) | — | — | 2,652 | Disposed |
| Nov. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (329) | — | — | 329 | Disposed |
| Sept. 6, 2024 | MRNA | Restricted Stock Units | Common Stock (1,139) | — | — | 1,139 | Disposed |
| Aug. 30, 2024 | MRNA | Restricted Stock Units | Common Stock (233) | — | — | 233 | Disposed |
| Aug. 28, 2024 | MRNA | Restricted Stock Units | Common Stock (329) | — | — | 329 | Disposed |
| Aug. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (2,652) | — | — | 2,652 | Disposed |
| June 7, 2024 | MRNA | Restricted Stock Units | Common Stock (9,108) | — | — | 9,108 | Disposed |
| June 7, 2024 | MRNA | Restricted Stock Units | Common Stock (1,139) | — | — | 1,139 | Disposed |
| May 31, 2024 | MRNA | Restricted Stock Units | Common Stock (232) | — | — | 232 | Disposed |
| May 28, 2024 | MRNA | Restricted Stock Units | Common Stock (328) | — | — | 328 | Disposed |
| May 24, 2024 | MRNA | Restricted Stock Units | Common Stock (2,652) | — | — | 2,652 | Disposed |
| March 7, 2024 | MRNA | Restricted Stock Units | Common Stock (1,138) | — | — | 1,138 | Disposed |
| March 1, 2024 | MRNA | Restricted Stock Units | Common Stock (233) | — | — | 233 | Disposed |
| Feb. 28, 2024 | MRNA | Restricted Stock Units | Common Stock (1,315) | — | — | 1,315 | Disposed |
| Feb. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (10,609) | $0.00 | — | 10,609 | Acquired |
| Feb. 27, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock (60,216) | $96.20 | Feb. 27, 2034 | 60,216 | Acquired |
| Feb. 27, 2024 | MRNA | Restricted Stock Units | Common Stock (12,377) | $0.00 | — | 12,377 | Acquired |
| Feb. 27, 2024 | MRNA | Stock Option (Right to Buy) | Common Stock (23,635) | $96.20 | Feb. 27, 2034 | 23,635 | Acquired |
| Dec. 7, 2023 | MRNA | Restricted Stock Units | Common Stock (1,139) | — | — | 1,139 | Disposed |
| Dec. 1, 2023 | MRNA | Restricted Stock Units | Common Stock (232) | — | — | 232 | Disposed |
| Sept. 7, 2023 | MRNA | Restricted Stock Units | Common Stock (1,138) | — | — | 1,138 | Disposed |
| Sept. 1, 2023 | MRNA | Restricted Stock Units | Common Stock (233) | — | — | 233 | Disposed |
| June 7, 2023 | MRNA | Restricted Stock Units | Common Stock (1,139) | — | — | 1,139 | Disposed |
| June 1, 2023 | MRNA | Restricted Stock Units | Common Stock (232) | — | — | 232 | Disposed |
| March 7, 2023 | MRNA | Restricted Stock Units | Common Stock (1,138) | $0.00 | — | 1,138 | Disposed |
| March 1, 2023 | MRNA | Restricted Stock Units | Common Stock (930) | $0.00 | — | 930 | Disposed |
| Feb. 28, 2023 | MRNA | Restricted Stock Units | Common Stock (5,260) | $0.00 | — | 5,260 | Acquired |
| Feb. 28, 2023 | MRNA | Stock Option (Right to Buy) | Common Stock (20,040) | $138.81 | Feb. 28, 2033 | 20,040 | Acquired |
| Dec. 7, 2022 | MRNA | Restricted Stock Units | Common Stock (1,139) | $0.00 | — | 1,139 | Disposed |
| Sept. 7, 2022 | MRNA | Restricted Stock Units | Common Stock (1,138) | $0.00 | — | 1,138 | Disposed |
| June 7, 2022 | MRNA | Restricted Stock Units | Common Stock (4,554) | $0.00 | — | 4,554 | Disposed |
| March 1, 2022 | MRNA | Restricted Stock Units | Common Stock (3,721) | $0.00 | — | 3,721 | Acquired |
| March 1, 2022 | MRNA | Stock Option (Right to Buy) | Common Stock (15,091) | $149.52 | March 1, 2032 | 15,091 | Acquired |
| June 7, 2021 | MRNA | Restricted Stock Units | Common Stock (9,108) | $0.00 | — | 9,108 | Acquired |
| June 7, 2021 | MRNA | Restricted Stock Units | Common Stock (18,217) | $0.00 | — | 18,217 | Acquired |
| June 7, 2021 | MRNA | Stock Option (Right to Buy) | Common Stock (42,169) | $219.57 | June 7, 2031 | 42,169 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 22, 2021 | RFL | Class B Common Stock, par value $.01 per share | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MRNA
Chief Legal Officer and Corporate Secretary| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $784,616 | — | — | — | $583,200 | — | $24,103 | $4,312,496 |
| 2021 | $381,096 | $250,000 | $6,000,000 | $4,000,000 | $344,000 | — | $514,051 | $11,489,147 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.